Invention Grant
- Patent Title: Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
-
Application No.: US16343826Application Date: 2017-11-24
-
Publication No.: US11236083B2Publication Date: 2022-02-01
- Inventor: Jun Xian
- Applicant: NEW ERA PHARMA, INC.
- Applicant Address: US MA Southborough
- Assignee: NEW ERA PHARMA, INC.
- Current Assignee: NEW ERA PHARMA, INC.
- Current Assignee Address: US MA Southborough
- Agency: TomanageIP
- Agent Anna Tsang
- International Application: PCT/US2017/063179 WO 20171124
- International Announcement: WO2018/106459 WO 20180614
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D403/04 ; C07D407/14 ; C07D471/04 ; C07D231/56 ; C07D401/10 ; C07D403/10 ; C07D405/12 ; C07D413/12 ; C07D487/16 ; C07D491/06
Abstract:
The present invention provides compounds of Formula (I) which can be used as SGK inhibitors; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by SGK by administering the compounds of the invention.
Public/Granted literature
- US20210032239A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING SGK ACTIVITY, AND METHODS THEREOF Public/Granted day:2021-02-04
Information query
